MultiplexDX
About
MultiplexDX focuses on precision cancer diagnostics, developing visualized diagnostic tests aimed at reducing misdiagnosis in oncology. Its work is particularly focused on breast cancer and improving clinical decision confidence. By 2026, the company is a high-impact biotech research player in the Slovak ecosystem with expanding clinical collaborations.
Investors 2
- Crowdberry Venture Capital · Bratislava
- Neulogy Ventures Venture Capital · Bratislava
Connection map
Every node here is a row in the lists above — the map is a second view of the same connections, not another source of them.
Recent news
- An Extraordinary Milestone: €13.72 Million Secured to Advance Breast Cancer Diagnostics 2025-03-01 · MultiplexDX
- MultiplexDX raises over €7 Million investment for personalized breast cancer treatment 2024-10-15 · Innovate Slovakia